98%
921
2 minutes
20
Antibody-drug conjugates (ADCs) represent a novel approach to cancer treatment. Enfortumab vedotin (PADCEV), as a prominent example, has demonstrated remarkable clinical efficacy. However, its ocular toxicity has raised concerns. This study aimed to explore the molecular mechanisms underlying PADCEV-induced ocular toxicity. SD rats, whose ocular structures are similar to those of humans, were selected to establish an ocular toxicity model to mimic the human response. In vitro experiments were conducted using human primary corneal epithelial cells, HCE-T. The results confirmed that nectin-4 plays a crucial role in the cellular uptake of PADCEV, and non-specific pinocytosis is also involved. Additionally, a variant was obtained by introducing point mutations in the Fc region of PADCEV, which was found to reduce corneal epithelial toxicity. The findings of this study not only deepen our understanding of ADC-induced ocular toxicity but also provide new insights into optimizing ADC design and enhancing treatment safety.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12154390 | PMC |
http://dx.doi.org/10.3390/ijms26114996 | DOI Listing |
J Steroid Biochem Mol Biol
September 2025
Biochemistry and Phytochemistry Research Division, Jubilee Centre for Medical Research, Thrissur, Kerala, 680005, India. Electronic address:
7-Ketocholesterol (7-KC) is a biologically active oxysterol formed through the oxidation of cholesterol, predominantly under conditions of oxidative stress. It is generated both enzymatically in specific tissues such as the brain and liver, and non-enzymatically via reactive oxygen species (ROS), especially in aging tissues and heat-processed animal-derived foods. 7-KC exerts multifaceted effects on human health, extending beyond lipid metabolism to disrupt glucose and amino acid utilization, impair mitochondrial function, and provoke endoplasmic reticulum (ER) stress.
View Article and Find Full Text PDFEcotoxicol Environ Saf
September 2025
Department of Orthordontics, School and Hospital of Stomatology, Guangdong Engineering Research Center of Oral Restoration and Reconstruction & Guangzhou Key Laboratory of Basic and Applied Research of Oral Regenerative Medicine, Guangzhou Medical University, Guangzhou, China. Electronic address: 20
Nanomaterials are widely used. The gases emitted from industrial manufacturing contain nanoparticles, which increases the chance of nanomaterials coming into contact with the eyes. Nanomaterials may cause damage to the eyeball wall and eye contents, manifested as keratitis, neovascularization of the iris, vitreous inflammation, retinitis, etc.
View Article and Find Full Text PDFESMO Open
September 2025
Sarah Cannon Research Institute United Kingdom, London, UK. Electronic address:
Background: Antibody-drug conjugates (ADCs) combine targeted monoclonal antibodies with cytotoxic payloads and are an emerging modality in systemic cancer therapy. Thirteen ADCs are Food and Drug Administration approved, with many more in development. However, design and use remain challenging, with issues including on/off-target toxicity, resistance from prior exposure to payload classes, and optimal target/payload selection.
View Article and Find Full Text PDFFront Med (Lausanne)
August 2025
Xiamen Eye Center and Eye Institute of Xiamen University, School of Medicine, Xiamen, China.
To investigate corneal deposits in a patient undergoing long-term chlorpromazine therapy using confocal microscopy with the HRT II Rostock Corneal Module. We reported a 45-year-old woman with a 7-year history of chlorpromazine therapy presented with bilateral photophobia and a 4-year history of gradual-onset blurred vision. Slit-lamp examination revealed yellowish deposits in the corneal endothelium and Descemet's membrane.
View Article and Find Full Text PDFAnn Med Surg (Lond)
September 2025
The Maldives National University, Malé, Maldives.
Uveal melanoma, the most common primary intraocular malignancy in adults, presents a significant challenge due to its high metastatic potential and the need to preserve vision during treatment. While conventional therapies such as plaque brachytherapy and proton beam radiation aim to balance tumor control with ocular preservation, recent advances in artificial intelligence (AI) and machine learning (ML) offer transformative potential in personalizing radiation dosing. By integrating radiologic features with genomic markers such as BAP1 mutations, monosomy 3, and chromosome 8q gain, AI models can predict tumor radiosensitivity and guide dose modulation based on individual tumor biology.
View Article and Find Full Text PDF